• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COV2Var,一个 SARS-CoV-2 遗传变异的功能注释数据库。

COV2Var, a function annotation database of SARS-CoV-2 genetic variation.

机构信息

Department of Laboratory Medicine and West China Biomedical Big Data Center, West China Hospital, Sichuan University, Chengdu 610041, China.

Med-X Center for Informatics, Sichuan University, Chengdu 610041, China.

出版信息

Nucleic Acids Res. 2024 Jan 5;52(D1):D701-D713. doi: 10.1093/nar/gkad958.

DOI:10.1093/nar/gkad958
PMID:37897356
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10767816/
Abstract

The COVID-19 pandemic, caused by the coronavirus SARS-CoV-2, has resulted in the loss of millions of lives and severe global economic consequences. Every time SARS-CoV-2 replicates, the viruses acquire new mutations in their genomes. Mutations in SARS-CoV-2 genomes led to increased transmissibility, severe disease outcomes, evasion of the immune response, changes in clinical manifestations and reducing the efficacy of vaccines or treatments. To date, the multiple resources provide lists of detected mutations without key functional annotations. There is a lack of research examining the relationship between mutations and various factors such as disease severity, pathogenicity, patient age, patient gender, cross-species transmission, viral immune escape, immune response level, viral transmission capability, viral evolution, host adaptability, viral protein structure, viral protein function, viral protein stability and concurrent mutations. Deep understanding the relationship between mutation sites and these factors is crucial for advancing our knowledge of SARS-CoV-2 and for developing effective responses. To fill this gap, we built COV2Var, a function annotation database of SARS-CoV-2 genetic variation, available at http://biomedbdc.wchscu.cn/COV2Var/. COV2Var aims to identify common mutations in SARS-CoV-2 variants and assess their effects, providing a valuable resource for intensive functional annotations of common mutations among SARS-CoV-2 variants.

摘要

由冠状病毒 SARS-CoV-2 引起的 COVID-19 大流行导致数百万人丧生和全球严重的经济后果。每次 SARS-CoV-2 复制时,其基因组都会获得新的突变。SARS-CoV-2 基因组中的突变导致了传染性的增加、严重的疾病结果、免疫反应的逃避、临床表现的变化以及疫苗或治疗效果的降低。迄今为止,多种资源提供了已检测突变的列表,但没有关键的功能注释。缺乏研究来检查突变与疾病严重程度、致病性、患者年龄、患者性别、种间传播、病毒免疫逃逸、免疫反应水平、病毒传播能力、病毒进化、宿主适应性、病毒蛋白结构、病毒蛋白功能、病毒蛋白稳定性和并发突变等各种因素之间的关系。深入了解突变位点与这些因素之间的关系对于推进我们对 SARS-CoV-2 的认识以及开发有效的应对措施至关重要。为了填补这一空白,我们构建了 COV2Var,这是一个 SARS-CoV-2 遗传变异的功能注释数据库,可在 http://biomedbdc.wchscu.cn/COV2Var/ 上获得。COV2Var 的目标是识别 SARS-CoV-2 变异株中的常见突变并评估其影响,为 SARS-CoV-2 变异株中常见突变的密集功能注释提供了有价值的资源。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e122/10767816/970e9bc44d18/gkad958fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e122/10767816/20da291e4e5f/gkad958figgra1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e122/10767816/41d21fdb514b/gkad958fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e122/10767816/7b9c46fa1c1f/gkad958fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e122/10767816/bd70ef577bcc/gkad958fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e122/10767816/970e9bc44d18/gkad958fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e122/10767816/20da291e4e5f/gkad958figgra1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e122/10767816/41d21fdb514b/gkad958fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e122/10767816/7b9c46fa1c1f/gkad958fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e122/10767816/bd70ef577bcc/gkad958fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e122/10767816/970e9bc44d18/gkad958fig4.jpg

相似文献

1
COV2Var, a function annotation database of SARS-CoV-2 genetic variation.COV2Var,一个 SARS-CoV-2 遗传变异的功能注释数据库。
Nucleic Acids Res. 2024 Jan 5;52(D1):D701-D713. doi: 10.1093/nar/gkad958.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Long-term serial passaging of SARS-CoV-2 reveals signatures of convergent evolution.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的长期连续传代揭示了趋同进化的特征。
J Virol. 2025 Jul 22;99(7):e0036325. doi: 10.1128/jvi.00363-25. Epub 2025 Jun 9.
4
Measures implemented in the school setting to contain the COVID-19 pandemic.学校为控制 COVID-19 疫情而采取的措施。
Cochrane Database Syst Rev. 2022 Jan 17;1(1):CD015029. doi: 10.1002/14651858.CD015029.
5
Characterization of SARS-CoV-2 intrahost genetic evolution in vaccinated and non-vaccinated patients from the Kenyan population.肯尼亚人群中接种疫苗和未接种疫苗患者体内 SARS-CoV-2 宿主内基因进化特征分析
J Virol. 2025 Jun 17;99(6):e0048225. doi: 10.1128/jvi.00482-25. Epub 2025 May 6.
6
SARS-CoV-2 CoCoPUTs: analyzing GISAID and NCBI data to obtain codon statistics, mutations, and free energy over a multiyear period.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的密码子使用情况分析:通过分析全球共享流感数据倡议组织(GISAID)和美国国立生物技术信息中心(NCBI)的数据,获取多年来的密码子统计信息、突变情况和自由能。
Virus Evol. 2025 Jan 17;11(1):veae115. doi: 10.1093/ve/veae115. eCollection 2025.
7
SARS-CoV-2 ORF3a induces COVID-19-associated kidney injury through HMGB1-mediated cytokine production.SARS-CoV-2 ORF3a 通过 HMGB1 介导体细胞因子产生诱导 COVID-19 相关肾损伤。
mBio. 2024 Nov 13;15(11):e0230824. doi: 10.1128/mbio.02308-24. Epub 2024 Sep 30.
8
Physical interventions to interrupt or reduce the spread of respiratory viruses.物理干预措施以阻断或减少呼吸道病毒的传播。
Cochrane Database Syst Rev. 2023 Jan 30;1(1):CD006207. doi: 10.1002/14651858.CD006207.pub6.
9
Nanopore sequencing reveals the genomic diversity of the variants of concern of SARS-CoV-2 during 2021 disease outbreak in Pakistan.纳米孔测序揭示了2021年巴基斯坦疾病爆发期间新冠病毒变异株的基因组多样性。
Sci Rep. 2025 Aug 1;15(1):28129. doi: 10.1038/s41598-025-12774-1.
10
The effect of sample site and collection procedure on identification of SARS-CoV-2 infection.样本采集部位和采集程序对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染鉴定的影响。
Cochrane Database Syst Rev. 2024 Dec 16;12(12):CD014780. doi: 10.1002/14651858.CD014780.

引用本文的文献

1
An Italian Single-Center Genomic Surveillance Study: Two-Year Analysis of SARS-CoV-2 Spike Protein Mutations.一项意大利单中心基因组监测研究:新冠病毒刺突蛋白突变的两年分析
Int J Mol Sci. 2025 Aug 5;26(15):7558. doi: 10.3390/ijms26157558.
2
The role of intrinsically disordered regions of SARS-CoV-2 nucleocapsid and non-structural protein 1 proteins.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)核衣壳蛋白和非结构蛋白1的内在无序区域的作用
Front Chem. 2025 Jun 11;13:1597656. doi: 10.3389/fchem.2025.1597656. eCollection 2025.
3
The NSP6-L260F substitution in SARS-CoV-2 BQ.1.1 and XBB.1.16 lineages compensates for the reduced viral polymerase activity caused by mutations in NSP13 and NSP14.

本文引用的文献

1
Genomic Surveillance Reveals the Rapid Expansion of the XBB Lineage among Circulating SARS-CoV-2 Omicron Lineages in Southeastern Wisconsin, USA.基因组监测揭示了美国威斯康星州东南部流行的 SARS-CoV-2 奥密克戎谱系中 XBB 谱系的快速扩张。
Viruses. 2023 Sep 16;15(9):1940. doi: 10.3390/v15091940.
2
Chasing SARS-CoV-2 XBB.1.16 Recombinant Lineage in India and the Clinical Profile of XBB.1.16 Cases in Maharashtra, India.追踪印度的新冠病毒XBB.1.16重组谱系以及印度马哈拉施特拉邦XBB.1.16病例的临床概况
Cureus. 2023 Jun 1;15(6):e39816. doi: 10.7759/cureus.39816. eCollection 2023 Jun.
3
XBB.1.16 Omicron subvariant rise to a variant of interest: Implications for global alertness and preparedness.
严重急性呼吸综合征冠状病毒2(SARS-CoV-2)BQ.1.1和XBB.1.16谱系中的NSP6-L260F替代可弥补由NSP13和NSP14突变导致的病毒聚合酶活性降低。
J Virol. 2025 Jun 17;99(6):e0065625. doi: 10.1128/jvi.00656-25. Epub 2025 May 13.
4
Characterization of SARS-CoV-2 intrahost genetic evolution in vaccinated and non-vaccinated patients from the Kenyan population.肯尼亚人群中接种疫苗和未接种疫苗患者体内 SARS-CoV-2 宿主内基因进化特征分析
J Virol. 2025 Jun 17;99(6):e0048225. doi: 10.1128/jvi.00482-25. Epub 2025 May 6.
5
Restoring flowcell type and basecaller configuration from FASTQ files of nanopore sequencing data.从纳米孔测序数据的FASTQ文件中恢复流动槽类型和碱基识别器配置。
Nat Commun. 2025 May 2;16(1):4102. doi: 10.1038/s41467-025-59378-x.
6
Characterization of SARS-CoV-2 intrahost genetic evolution in vaccinated and non-vaccinated patients from the Kenyan population.肯尼亚人群中接种疫苗和未接种疫苗患者体内新冠病毒的宿主内基因进化特征分析
medRxiv. 2025 Mar 7:2025.03.03.25323296. doi: 10.1101/2025.03.03.25323296.
7
VITALdb: to select the best viroinformatics tools for a desired virus or application.VITALdb:为所需病毒或应用选择最佳的病毒信息学工具。
Brief Bioinform. 2025 Mar 4;26(2). doi: 10.1093/bib/bbaf084.
8
GRAMEP: an alignment-free method based on the maximum entropy principle for identifying SNPs.GRAMEP:一种基于最大熵原理的无比对单核苷酸多态性识别方法。
BMC Bioinformatics. 2025 Feb 25;26(1):66. doi: 10.1186/s12859-025-06037-z.
9
AnnCovDB: a manually curated annotation database for mutations in SARS-CoV-2 spike protein.安科维数据库(AnnCovDB):一个人工整理的关于严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白突变的注释数据库。
Database (Oxford). 2025 Feb 12;2025. doi: 10.1093/database/baaf002.
10
Emergence of Omicron FN.1 a descendent of BQ.1.1 in Botswana.奥密克戎FN.1(BQ.1.1的一个分支)在博茨瓦纳出现。
Virus Evol. 2024 Nov 22;10(1):veae095. doi: 10.1093/ve/veae095. eCollection 2024.
XBB.1.16奥密克戎亚变体成为关注变体:对全球警惕性和防范措施的影响。
J Taibah Univ Med Sci. 2023 Dec;18(6):1285-1287. doi: 10.1016/j.jtumed.2023.05.013. Epub 2023 May 23.
4
Virological characteristics of the SARS-CoV-2 omicron XBB.1.16 variant.严重急性呼吸综合征冠状病毒2型奥密克戎XBB.1.16变体的病毒学特征
Lancet Infect Dis. 2023 Jun;23(6):655-656. doi: 10.1016/S1473-3099(23)00278-5. Epub 2023 May 3.
5
The evolution of SARS-CoV-2.严重急性呼吸综合征冠状病毒2的进化
Nat Rev Microbiol. 2023 Jun;21(6):361-379. doi: 10.1038/s41579-023-00878-2. Epub 2023 Apr 5.
6
Outbreak.info genomic reports: scalable and dynamic surveillance of SARS-CoV-2 variants and mutations.暴发信息基因组报告:可扩展和动态监测 SARS-CoV-2 变体和突变。
Nat Methods. 2023 Apr;20(4):512-522. doi: 10.1038/s41592-023-01769-3. Epub 2023 Feb 23.
7
Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution.印迹 SARS-CoV-2 体液免疫诱导奥密克戎 RBD 进化趋同。
Nature. 2023 Feb;614(7948):521-529. doi: 10.1038/s41586-022-05644-7. Epub 2022 Dec 19.
8
RASCL: Rapid Assessment of Selection in CLades through molecular sequence analysis.RASCL:通过分子序列分析快速评估 CLade 中的选择。
PLoS One. 2022 Nov 2;17(11):e0275623. doi: 10.1371/journal.pone.0275623. eCollection 2022.
9
Comparative analysis of within-host diversity among vaccinated COVID-19 patients infected with different SARS-CoV-2 variants.接种疫苗的COVID-19患者中感染不同SARS-CoV-2变体的宿主内多样性比较分析。
iScience. 2022 Nov 18;25(11):105438. doi: 10.1016/j.isci.2022.105438. Epub 2022 Oct 25.
10
Antigenic characterization of the SARS-CoV-2 Omicron subvariant BA.2.75.SARS-CoV-2 奥密克戎变异株 BA.2.75 的抗原特征分析。
Cell Host Microbe. 2022 Nov 9;30(11):1512-1517.e4. doi: 10.1016/j.chom.2022.09.002. Epub 2022 Sep 6.